24
Participants
Start Date
October 31, 2006
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Theophylline
"Patients assigned to study group, will receive slow-release theophylline at a dose of 10 mg/kg, titrated to blood levels between 55-110 umol/L, for a period of 4 weeks.~Patients assigned to placebo group will receive identical-appearing placebo tablets for the same period of time."
Ottawa Hospital, General campus, Ottawa
Lead Sponsor
Ontario Lung Association
OTHER
Ottawa Hospital Research Institute
OTHER